Tech Company Financing Transactions
Optain Funding Round
Insight Venture Partners, Memorial Hermann Hospital and Meridian Capital invested in a $26 million Series A funding round for Optain. The round closed on 9/10/2025.
Transaction Overview
Company Name
Announced On
9/10/2025
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the growth of its global footprint in Australia, Europe, the Middle East, and Southeast Asia.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Optain improves the speed to diagnosis, democratizes access to specialized disease screening, and reduces the risk of missed diagnoses. Optain is a medical device and software company based in New York City and with roots in Australia. We are innovating to set the new benchmark in accurate and efficient patient care. We empower people with advanced AI and automation, using the eye as the gateway to detect and prevent diseases in their earliest stages.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff Dunkel
Chief Operating Officer
Jason Sun
Chief Technical Officer
Wei Meng
Browse more venture capital transactions:
Prev: 9/10/2025: Reflection AI venture capital transaction
Next: 9/10/2025: Klarna venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs